Seminars in Arthritis and Rheumatism This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation
Spondyloarthritis (SpA), a chronic inflammatory, rheumatic disease, and hidradenitis suppurativa (HS), a chronic, debilitating, inflammatory skin disease, share several clinical and pathophysiological features, such as the association with inflammatory bowel disease and elevated cytokine levels IL-17 and TNF- α. Recently, SpA was reported to be more prevalent (2.3–28.2%) in patients with HS than in the general population. Conversely, the prevalence of HS in SpA is not exactly known. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 20, 2018 Category: Rheumatology Authors: Angelique Rondags, Suzanne Arends, Freke R. Wink, Barbara Horv áth, Anneke Spoorenberg Source Type: research

High prevalence of hidradenitis suppurativa in axial spondyloarthritis patients: A possible new extra-articular manifestation
Spondyloarthritis (SpA), a chronic inflammatory, rheumatic disease, and hidradenitis suppurativa (HS), a chronic, debilitating, inflammatory skin disease, share several clinical en pathophysiological features, such as the association with inflammatory bowel disease and elevated cytokine levels IL-17 and TNF- α. Recently, SpA was reported to be more prevalent (2.3-28.2%) in patients with HS than in the general population. Conversely, the prevalence of HS in SpA is not exactly known. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 20, 2018 Category: Rheumatology Authors: Angelique Rondags, Suzanne Arends, Freke R. Wink, Barbara Horv áth, Anneke Spoorenberg Source Type: research

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis
Increased cardiovascular risk in rheumatoid arthritis (RA) is well established. Examining traditional cardiovascular risk factors alone underestimates cardiovascular risk in RA. Systematic inflammation, measured by erythrocyte sedimentation rate or C-reactive protein is also a major risk factor. However, the contribution of traditional cardiovascular risk factors (such as obesity and hyperlipidaemia) compared to inflammation is uncertain in psoriatic arthritis (PsA) and RA. We examine the incidence of major adverse cardiac events (MACE) among patients with RA, PsA psoriasis, and controls adjusting for risk factors, inflamm...
Source: Seminars in Arthritis and Rheumatism - March 17, 2018 Category: Rheumatology Authors: Roxanne Cooksey, Sinead Brophy, Jonathan Kennedy, Fabiola Fernandez Gutierrez, Tim Pickles, Ruth Davies, Vincent Piguet, Ernest Choy Source Type: research

Statin use and mortality in gout: A general population-based cohort study
We examined the potential survival benefit of statin use among gout patients in the general population. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 17, 2018 Category: Rheumatology Authors: Sarah F. Keller, Sharan K. Rai, Na Lu, Amar Oza, April M. Jorge, Yuqing Zhang, Hyon K. Choi Source Type: research

Serum Bisphenol A is an independent risk factor of hyperuricemia: A 6-year prospective study
This study aims to evaluate whether serum Bisphenol A (BPA) is a risk factor for hyperuricemia. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 17, 2018 Category: Rheumatology Authors: Jinbo Hu, Chuan Peng, Jiayu Li, Rufei Gao, Aipin Zhang, Linqiang Ma, Linkun Zhang, Yi Yang, Qingfeng Cheng, Yue Wang, Ting Luo, Zhihong Wang, Hua Qing, Shumin Yang, Qifu Li Source Type: research

Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis
Increased cardiovascular risk in rheumatoid arthritis (RA) is well established. Examining traditional cardiovascular risk factors alone underestimates cardiovascular risk in RA. Systematic inflammation, measured by erythrocyte sedimentation rate or C-reactive protein is also a major risk factor. However, the contribution of traditional cardiovascular risk factors (such as obesity and hyperlipidaemia) compared to inflammation is uncertain in psoriatic arthritis (PsA) and RA. We examine the incidence of Major Adverse Cardiac Events (MACE) among patients with RA, PsA, psoriasis and controls adjusting for risk factors, inflamm...
Source: Seminars in Arthritis and Rheumatism - March 17, 2018 Category: Rheumatology Authors: Roxanne Cooksey, Sinead Brophy, Jonathan Kennedy, Fabiola Fernandez Gutierrez, Tim Pickles, Ruth Davies, Vincent Piguet, Ernest Choy Source Type: research

Serum Bisphenol A is an independent risk factor of hyperuricemia: A six-year prospective study
This study aims to evaluate whether serum Bisphenol A (BPA) is a risk factor for hyperuricemia. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 17, 2018 Category: Rheumatology Authors: Jinbo Hu, Chuan Peng, Jiayu Li, Rufei Gao, Aipin Zhang, Linqiang Ma, Linkun Zhang, Yi Yang, Qingfeng Cheng, Yue Wang, Ting Luo, Zhihong Wang, Hua Qing, Shumin Yang, Qifu Li Source Type: research

Trends of Informed Consent Forms for Industry-Sponsored Clinical Trials in Rheumatology over a 17-year Period: Readability, and Assessment of Patients ’ Health Literacy and Perceptions
To assess trends in the length and readability of informed consent forms (ICFs) for industry-sponsored multinational clinical trials (RCTs) in rheumatology over a 17-year period. Additionally, to assess the health literacy (HL) and perceptions of ICFs among participants of current RCTs. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 16, 2018 Category: Rheumatology Authors: Hector de la Mora-Molina, Aldo Barajas-Ochoa, Leon Sandoval-Garcia, Martha Navarrete-Lorenzon, Edgar A. Casta ñeda-Barragan, José Dionisio Castillo-Ortiz, Francisco Javier Aceves-Avila, Jose Yañez, Lilia Patricia Bustamante-Montes, Cesar Ramos-Remus Source Type: research

The use of routinely collected patient-reported outcome measures in rheumatoid arthritis
This study systematically reviewed validated patient-reported outcome measures (PROMs) for rheumatoid arthritis (RA), routinely collected in clinical practice, and evaluated objectives of their use. An additional survey conducted among identified RA registries provided additional information about collection of PROMs.Medline Ovid and Embase were searched for observational studies using data of RA registries/cohorts, published between 2011 and 2016. The search combined a validated search algorithm for PROMs and RA. (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 15, 2018 Category: Rheumatology Authors: Micka ël Hiligsmann, Susanne Rademacher, K. Julia Kaal, Nick Bansback, Mark Harrison Source Type: research

Baseline patient reported outcomes are more consistent predictors of long-term functional disability than laboratory, imaging or joint count data in patients with early inflammatory arthritis: A systematic review
To assess baseline predictors of long-term functional disability in patients with inflammatory arthritis (IA). (Source: Seminars in Arthritis and Rheumatism)
Source: Seminars in Arthritis and Rheumatism - March 14, 2018 Category: Rheumatology Authors: James M. Gwinnutt, Charlotte A. Sharp, Deborah P.M. Symmons, Mark Lunt, Suzanne M.M. Verstappen Source Type: research